Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2025-12-29 @ 6:39 AM
Study NCT ID:
NCT01246934
Status:
COMPLETED
Last Update Posted:
2010-11-24
First Post:
2010-11-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Segment Transport Versus Acute Shortening In The Treatment of Tibial Pseudarthroses With Bone Loss
Sponsor:
Bezmialem Vakif University
Organization:
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2010-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In this study the investigators are presenting the advantages as well as the disadvantages of ACUTE SHORTENING AND RELENGTHENINIG VS SEGMENT TRANSPORT methods.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: